AM
Insider
Andrew Hollman Meyer
Chief Business OfficerAndrew Hollman Meyer (Chief Business Officer) filed 4 Form 4 reports in the past 24 months (0 purchases, 4 sales), most often in JANX. The largest single filing was $664K of JANX (12,134 sh across 3 lots, as filed), executed Jan 2 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
4
0 buys · 4 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.4M
shares × price, as filed
Last traded
Oct 28 2025
Filed Oct 30 2025
Volume by month
Buys $0
Sells $1.4M
Shares × price, as filed · by filing month · past 24 months
Most traded names
JANX
JANX
0 buys · 4 sells
4 filings
Recent filings
JANXSALE
Janux Therapeutics, Inc.
View filing →
$501K16,665 sh × $30.06
Exec Oct 28 2025
Filed Oct 30 2025 · 5:30 PM ET JANXSALE Janux Therapeutics, Inc. View filing → $100K
3,334 sh × $30.00
Exec Apr 21 2025
Filed Apr 23 2025 · 5:30 PM ET JANXSALE Janux Therapeutics, Inc. View filing → $102K
2,418 sh × $42.08
Exec Feb 3 2025
Filed Feb 5 2025 · 5:30 PM ET JANXSALE Janux Therapeutics, Inc. View filing → $664K
12,134 sh across 3 lots
Exec Jan 2 2025
Filed Jan 3 2025 · 5:30 PM ET